Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Qingqi, Ren"'
Publikováno v:
Radiology Case Reports, Vol 19, Iss 8, Pp 3258-3262 (2024)
Clonorchis sinensis infections persist globally among humans. These pathogens mainly inhabit the intrahepatic biliary system. Most individuals with clonorchiasis exhibit mild symptoms. The absence of distinctive symptoms often results in delayed diag
Externí odkaz:
https://doaj.org/article/80e789bd899c46579193fe7bd0a018b0
Autor:
Dandan Zhu, Haihong Wang, Wei Wu, Shuaipeng Geng, Guolin Zhong, Yunfei Li, Han Guo, Guanghui Long, Qingqi Ren, Yi Luan, Chaohui Duan, Bing Wei, Jie Ma, Shiyong Li, Jun Zhou, Mao Mao
Publikováno v:
BMC Biology, Vol 21, Iss 1, Pp 1-11 (2023)
Abstract Background Circulating cell-free DNA (cfDNA) is a pool of short DNA fragments mainly released from apoptotic hematopoietic cells. Nevertheless, the precise physiological process governing the DNA fragmentation and molecular profile of cfDNA
Externí odkaz:
https://doaj.org/article/0f54e3c329094239927b0161d64dbaa0
Autor:
Erbao Chen, Yu He, Jing Jiang, Jing Yi, Zhilin Zou, Qiuzi Song, Qingqi Ren, Zewei Lin, Yi Lu, Jikui Liu, Jian Zhang
Publikováno v:
Experimental Hematology & Oncology, Vol 12, Iss 1, Pp 1-18 (2023)
Abstract Background Hepatocellular carcinoma (HCC) is one of the most lethal malignant tumors. Cell division cycle associated 8 (CDCA8) is an important multifactorial regulator in cancers. However, its up and downstream targets and effects in HCC are
Externí odkaz:
https://doaj.org/article/3b3217abf08a40ebb724e30d3ab0be20
Autor:
Erbao Chen, Jing Yi, Jing Jiang, Zhilin Zou, Yuqian Mo, Qingqi Ren, Zewei Lin, Yi Lu, Jian Zhang, Jikui Liu
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-18 (2022)
Abstract Background Fatty acid (FA) metabolism is considered the emerging cause of tumor development and metastasis, driving poor prognosis. Long non-coding RNAs (lncRNAs) are closely related to cancer progression and play important roles in FA metab
Externí odkaz:
https://doaj.org/article/5250ff807b204cf09ffe60a4f141b2f6
Autor:
Zilong Yan, Qingen Da, Zhangfu Li, Qirui Lin, Jing Yi, Yanze Su, Guanyin Yu, Qingqi Ren, Xu Liu, Zewei Lin, Jianhua Qu, Weihua Yin, Jikui Liu
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
NIMA-related kinase 7 (NEK7) is a serine/threonine kinase involved in cell cycle progression via mitotic spindle formation and cytokinesis. It has been related to multiple cancers, including breast cancer, hepatocellular cancer, lung cancer, and colo
Externí odkaz:
https://doaj.org/article/2d95ca608a39473d9fb665766a8e6f19
Autor:
Guanghui Long, Zhong Guolin, Feng Yumin, Zhang Feng, Mao Mao, Zuowei Meng, Qingqi Ren, Yan Chen, Shiyong Li, Wei Wu
Publikováno v:
The Journal of Molecular Diagnostics. 23:1174-1184
Liver cancer is the fifth-most common cancer worldwide, with the third-highest rate of cancer-related mortality. Hepatocellular carcinoma (HCC) is the leading pathologic subtype, contributing 85% to 90% of cases of primary liver cancer. Most HCC pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14e274c204ff26eaf6a7c417ec91b4eb
https://doi.org/10.1016/j.jmoldx.2021.06.003
https://doi.org/10.1016/j.jmoldx.2021.06.003
Autor:
Anli Yang, Zhiyong Guo, Qingqi Ren, Linwei Wu, Yi Ma, Anbin Hu, Dongping Wang, Haidan Ye, Xiaofeng Zhu, Weiqiang Ju, Xiaoshun He
Publikováno v:
PLoS ONE, Vol 12, Iss 11, p e0188190 (2017)
Prophylactic administration of hepatitis B immunoglobulin (HBIG) and nucleos(t)ide analogues (NAs) is the standard treatment for controlling hepatitis B virus (HBV) recurrence after liver transplantation (LT). Since lifelong use of HBIG is expensive
Externí odkaz:
https://doaj.org/article/ca89418550b0455a8a466b74d0f8b285
Publikováno v:
Evidence-based complementary and alternative medicine : eCAM. 2022
Background. Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide, and more prevalent among males than females. However, the biological role of enzyme 5α-reductase (SRD5A3), which plays a critical role in the androgen receptor s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b234a713df1c5855314dcfa1a554f580
https://pubmed.ncbi.nlm.nih.gov/36159555
https://pubmed.ncbi.nlm.nih.gov/36159555
Autor:
Fangli Yan, Xiang Pan, Kangfu Dai, Xiaoping Liu, Xinghan Jin, Qingqi Ren, Jing Quan, Shijie Zhang, Xiaorui Song, Jikui Liu
Publikováno v:
OncoTargets and Therapy. 12:1905-1915
Background Cholangiocarcinoma (CCA) is the second most common fatal primary hepatobiliary malignant carcinoma, characterized by early invasion and extremely poor outcomes. It is therefore necessary to identify a novel biomarker to better diagnose CAA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::71064fc82adde68c12f9e28c5d76d165
https://doi.org/10.2147/ott.s188134
https://doi.org/10.2147/ott.s188134
Bone marrow mesenchymal stem cells (BM-MSCs) have been shown to exert a potential therapeutic effect during tumor treatment and it has been proved that exosomes derived from BM-MSCs play crucial roles in the progression of malignant tumors. The curre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::720569efcff77068414f312b22418e41
https://doi.org/10.21203/rs.3.rs-453742/v1
https://doi.org/10.21203/rs.3.rs-453742/v1
